CU in the News

Thailand Starts Human Trials of Homegrown COVID-19 Vaccines

BANGKOK – Thailand has begun human trials with two of four homegrown vaccine candidates local scientists are developing against COVID-19, as the country scrambles to secure shots from abroad amid its worst wave of infections since the pandemic began.

The homegrown vaccines will not be ready for mass production in time to help Thailand fight off the latest wave. Officials and developers are hoping, though, that they will arrive in time to give Thailand — and maybe its neighbors — booster shots tailored to the main variants of the novel coronavirus by next year.

“The vaccine will be against the variants like the South African variant and the Indian variant and others, so that will be our strategy,” said Kiat Ruxrungtham, who is spearheading development of one of the most anticipated candidates at Chulalongkorn University’s Vaccine Research Center in Bangkok. …

Continue reading >>

Chula produces able graduates who become quality citizens for society.

Prof. Bundhit Eua-arporn President of Chulalongkorn University